Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04692571 · ClinicalTrials.gov registry record · Early Phase 1
EMG-Based Hand-Wrist Control: Study B Mirrored
A Early Phase 1 study, sponsored by Liberating Technologies.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
NCT04692571 is a Early Phase 1 study that has completed, run by Liberating Technologies. The registered enrollment target is 20 participants.
The verdict
NCT04692571, a Early Phase 1 study, has completed, sponsored by Liberating Technologies.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
Study assessing four-channel prosthesis controller, that compares contralateral (mirrored) EMG-force training to ipsilateral EMG-target training with both limb-absent and able-bodied subjects
Interventions
- DEVICE PSICON Measurement Apparatus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-06-29 |
| Est. Completion | 2020-08-24 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04692571
The ClinicalTrials.gov registry entry for NCT04692571 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Liberating Technologies, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PSICON Measurement Apparatus is the first listed.
NCT04692571 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04692571 about?
NCT04692571 is a clinical study titled "EMG-Based Hand-Wrist Control: Study B Mirrored". Study assessing four-channel prosthesis controller, that compares contralateral (mirrored) EMG-force training to ipsilateral EMG-target training with both limb-absent and able-bodied subjects
What is the current status of trial NCT04692571?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2017-06-29. Estimated completion is 2020-08-24.
What interventions are being tested in trial NCT04692571?
The interventions under investigation include: PSICON Measurement Apparatus (DEVICE).
Who is sponsoring clinical trial NCT04692571?
This trial is sponsored by Liberating Technologies, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.